Anti-inflammatory treatment of depression

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/GNT1027315

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Depression is the most prevalent health problem in young people, with a prevalence as high as 24 percent. There is evidence demonstrating a link between depression and chronic inflammation and oxidative stress, suggesting that drugs which modulate those factors may have antidepressant properties. This study is designed to establish whether the use of (i) rosuvastatin or (ii) aspirin, two drugs that modulate both the inflammatory and oxidative systems, reduce symptoms of depression in young people with major depression.

Funded Activity Details

Start Date: 01-01-2012

End Date: 01-01-2018

Funding Scheme: Project Grants

Funding Amount: $1,475,510.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Medical and Health Sciences not elsewhere classified

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

antidepressant therapy | aspirin | depression | immune modulation | inflammatory cytokines | mental health | oxidative stress | psychiatry | statins

Related Links